Regeneron Pharmaceuticals is focused on the development of pharmaceutical products for the treatment of serious medical conditions.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Eastview, near Tarrytown, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities (thus the name), it branched out into the study of both cytokine and tyrosine kinase receptors.
Some doctors who are not in Trump’s medical team believe that the President’s health conditions might be worse than it is being stated.
The REGN-COV2 treatment offered to COVID-19 patients have shown good results in reducing the viral load even in patients with not so strong immune system.
Regeneron Pharmaceuticals is going to repurchase $5B of its shares from Sanofi without changing their over-a-decade-long partnership as the race for coronavirus vaccine development intensifies.